CA Stock MarketDetailed Quotes

CVM.H CVR Medical Corp(Delisted)

Watchlist
  • 0.015
  • 0.0000.00%
15min DelayMarket Closed Jun 21 09:30 ET
1.61MMarket Cap-0.42P/E (TTM)

CVR Medical Corp(Delisted) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-201.65%-169.84K
-429.83%-93.67K
-471.84%-52.46K
51.01%-88.4K
-114.61%-51.32K
68.12%-56.3K
112.62%28.4K
92.94%-9.17K
91.81%-180.43K
307.29%351.18K
Net income from continuing operations
-6.19%-258.6K
-229.04%-190.59K
59.86%-134.88K
-948.22%-1.82M
-268.87%-1.39M
21.88%-243.52K
145.07%147.7K
5.23%-335.99K
96.62%-173.4K
167.57%820.62K
Depreciation and amortization
--0
--0
-49.18%31
6.90%248
3.33%62
6.90%62
12.50%63
5.17%61
-0.85%232
1.69%60
Asset impairment expenditure
----
----
----
--1.17M
----
----
----
----
--0
----
Remuneration paid in stock
-63.44%6.59K
98.98%-2.34K
-88.90%15.22K
82.57%-43.15K
105.59%32K
-83.29%18.01K
-321.40%-230.31K
21.98%137.15K
-133.38%-247.63K
-300.36%-571.91K
Other non cashItems
----
-3.68%9.65K
-3.67%9.19K
-120.24%-9.35K
----
----
--10.01K
--9.54K
--46.21K
----
Change In working capital
-54.58%72.05K
-11.23%89.61K
-67.81%57.97K
213.51%608.72K
200.81%169.07K
482.13%158.64K
7,228.74%100.94K
60.60%180.07K
-90.55%194.16K
-90.95%56.21K
-Change in receivables
-101.69%-253
97.70%-67
-154.01%-602
384.12%11.43K
59.71%-365
830.14%14.95K
-467.45%-2.91K
57.53%-237
-119.35%-4.02K
55.91%-906
-Change in prepaid assets
--0
--0
--0
262.62%48.11K
2,658.88%48.17K
-97.98%239
98.22%-148
-101.84%-148
116.80%13.27K
121.56%1.75K
-Change in payables and accrued expense
-49.60%72.31K
-13.77%89.68K
-67.54%58.57K
196.99%549.17K
119.03%121.27K
720.05%143.45K
1,302.97%104K
72.44%180.45K
-90.88%184.92K
-91.23%55.37K
Cash from discontinued investing activities
Operating cash flow
-201.65%-169.84K
-429.83%-93.67K
-471.84%-52.46K
51.01%-88.4K
-114.61%-51.32K
68.12%-56.3K
112.62%28.4K
92.94%-9.17K
91.81%-180.43K
307.29%351.18K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-55.50%12.02K
57.41%45K
-68.25%7.89K
9.48%197.78K
343.04%117.34K
-26.33%27.01K
-62.52%28.59K
-39.74%24.84K
-91.52%180.65K
-56.21%26.49K
Net issuance payments of debt
-55.50%12.02K
--0
-68.25%7.89K
-40.34%107.78K
3.24%27.34K
-26.33%27.01K
-62.52%28.59K
-39.74%24.84K
67.95%180.65K
-71.98%26.49K
Net common stock issuance
--0
----
----
--90K
--90K
--0
----
----
--0
----
Cash from discontinued financing activities
Financing cash flow
-55.50%12.02K
57.41%45K
-68.25%7.89K
9.48%197.78K
343.04%117.34K
-26.33%27.01K
-62.52%28.59K
-39.74%24.84K
-91.52%180.65K
-56.21%26.49K
Net cash flow
Beginning cash position
2,144.62%30.24K
636.55%17.31K
2,638.11%94.41K
6.65%3.45K
-18.30%4.84K
-97.41%1.35K
3.43%2.35K
6.65%3.45K
-95.67%3.23K
0.92%5.92K
Current changes in cash
-438.76%-157.82K
-185.41%-48.67K
-384.61%-44.58K
50,774.42%109.38K
-82.92%66.02K
80.32%-29.29K
138.30%56.99K
117.66%15.66K
100.30%215
454.91%386.59K
Effect of exchange rate changes
302.89%132.09K
206.22%61.6K
-94.06%-32.53K
---18.42K
106.05%23.55K
-68.12%32.79K
-129.22%-57.99K
-119.10%-16.76K
--0
-466.05%-389.06K
End cash Position
-6.94%4.5K
2,144.62%30.24K
636.55%17.31K
2,638.11%94.41K
2,638.11%94.41K
-18.30%4.84K
-97.41%1.35K
3.43%2.35K
6.65%3.45K
6.65%3.45K
Free cash from
-201.65%-169.84K
-429.83%-93.67K
-471.84%-52.46K
51.01%-88.4K
-114.25%-51.32K
69.66%-56.3K
112.62%28.4K
92.94%-9.17K
91.81%-180.43K
312.56%360.1K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -201.65%-169.84K-429.83%-93.67K-471.84%-52.46K51.01%-88.4K-114.61%-51.32K68.12%-56.3K112.62%28.4K92.94%-9.17K91.81%-180.43K307.29%351.18K
Net income from continuing operations -6.19%-258.6K-229.04%-190.59K59.86%-134.88K-948.22%-1.82M-268.87%-1.39M21.88%-243.52K145.07%147.7K5.23%-335.99K96.62%-173.4K167.57%820.62K
Depreciation and amortization --0--0-49.18%316.90%2483.33%626.90%6212.50%635.17%61-0.85%2321.69%60
Asset impairment expenditure --------------1.17M------------------0----
Remuneration paid in stock -63.44%6.59K98.98%-2.34K-88.90%15.22K82.57%-43.15K105.59%32K-83.29%18.01K-321.40%-230.31K21.98%137.15K-133.38%-247.63K-300.36%-571.91K
Other non cashItems -----3.68%9.65K-3.67%9.19K-120.24%-9.35K----------10.01K--9.54K--46.21K----
Change In working capital -54.58%72.05K-11.23%89.61K-67.81%57.97K213.51%608.72K200.81%169.07K482.13%158.64K7,228.74%100.94K60.60%180.07K-90.55%194.16K-90.95%56.21K
-Change in receivables -101.69%-25397.70%-67-154.01%-602384.12%11.43K59.71%-365830.14%14.95K-467.45%-2.91K57.53%-237-119.35%-4.02K55.91%-906
-Change in prepaid assets --0--0--0262.62%48.11K2,658.88%48.17K-97.98%23998.22%-148-101.84%-148116.80%13.27K121.56%1.75K
-Change in payables and accrued expense -49.60%72.31K-13.77%89.68K-67.54%58.57K196.99%549.17K119.03%121.27K720.05%143.45K1,302.97%104K72.44%180.45K-90.88%184.92K-91.23%55.37K
Cash from discontinued investing activities
Operating cash flow -201.65%-169.84K-429.83%-93.67K-471.84%-52.46K51.01%-88.4K-114.61%-51.32K68.12%-56.3K112.62%28.4K92.94%-9.17K91.81%-180.43K307.29%351.18K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -55.50%12.02K57.41%45K-68.25%7.89K9.48%197.78K343.04%117.34K-26.33%27.01K-62.52%28.59K-39.74%24.84K-91.52%180.65K-56.21%26.49K
Net issuance payments of debt -55.50%12.02K--0-68.25%7.89K-40.34%107.78K3.24%27.34K-26.33%27.01K-62.52%28.59K-39.74%24.84K67.95%180.65K-71.98%26.49K
Net common stock issuance --0----------90K--90K--0----------0----
Cash from discontinued financing activities
Financing cash flow -55.50%12.02K57.41%45K-68.25%7.89K9.48%197.78K343.04%117.34K-26.33%27.01K-62.52%28.59K-39.74%24.84K-91.52%180.65K-56.21%26.49K
Net cash flow
Beginning cash position 2,144.62%30.24K636.55%17.31K2,638.11%94.41K6.65%3.45K-18.30%4.84K-97.41%1.35K3.43%2.35K6.65%3.45K-95.67%3.23K0.92%5.92K
Current changes in cash -438.76%-157.82K-185.41%-48.67K-384.61%-44.58K50,774.42%109.38K-82.92%66.02K80.32%-29.29K138.30%56.99K117.66%15.66K100.30%215454.91%386.59K
Effect of exchange rate changes 302.89%132.09K206.22%61.6K-94.06%-32.53K---18.42K106.05%23.55K-68.12%32.79K-129.22%-57.99K-119.10%-16.76K--0-466.05%-389.06K
End cash Position -6.94%4.5K2,144.62%30.24K636.55%17.31K2,638.11%94.41K2,638.11%94.41K-18.30%4.84K-97.41%1.35K3.43%2.35K6.65%3.45K6.65%3.45K
Free cash from -201.65%-169.84K-429.83%-93.67K-471.84%-52.46K51.01%-88.4K-114.25%-51.32K69.66%-56.3K112.62%28.4K92.94%-9.17K91.81%-180.43K312.56%360.1K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data